Apexigen, Inc.
APGN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| R&D Expenses | $23 | $22 | $19 |
| G&A Expenses | $10 | $7 | $6 |
| SG&A Expenses | $10 | $7 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $33 | $29 | $25 |
| Operating Income | -$33 | -$29 | -$25 |
| % Margin | – | – | – |
| Other Income/Exp. Net | $1 | $0 | $0 |
| Pre-Tax Income | -$32 | -$29 | -$24 |
| Tax Expense | -$1 | -$0 | -$0 |
| Net Income | -$31 | -$29 | -$24 |
| % Margin | – | – | – |
| EPS | -1.59 | -0.93 | -0.76 |
| % Growth | -71% | -22.4% | – |
| EPS Diluted | -1.59 | -0.93 | -0.76 |
| Weighted Avg Shares Out | 20 | 31 | 31 |
| Weighted Avg Shares Out Dil | 20 | 31 | 31 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $0 | $0 |
| Interest Expense | -$1 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 |
| EBITDA | -$33 | -$29 | -$24 |
| % Margin | – | – | – |